
### [NCIT:C3844](http://purl.obolibrary.org/obo/NCIT_C3844)
**Label:** Gallbladder Carcinoma

**Subclasses:** [NCIT:C5745](http://purl.obolibrary.org/obo/NCIT_C5745) (Gallbladder Signet Ring Cell Carcinoma), [NCIT:C7649](http://purl.obolibrary.org/obo/NCIT_C7649) (Localized Gallbladder Carcinoma), [NCIT:C134675](http://purl.obolibrary.org/obo/NCIT_C134675) (Stage IV Gallbladder Cancer AJCC v8), [NCIT:C96890](http://purl.obolibrary.org/obo/NCIT_C96890) (Gallbladder Hepatoid Adenocarcinoma), [NCIT:C96891](http://purl.obolibrary.org/obo/NCIT_C96891) (Gallbladder Cribriform Carcinoma), [NCIT:C4439](http://purl.obolibrary.org/obo/NCIT_C4439) (Stage 0 Gallbladder Cancer AJCC v6 and v7), [NCIT:C134672](http://purl.obolibrary.org/obo/NCIT_C134672) (Stage III Gallbladder Cancer AJCC v8), [NCIT:C5743](http://purl.obolibrary.org/obo/NCIT_C5743) (Gallbladder Papillary Neoplasm with an Associated Invasive Carcinoma), [NCIT:C5744](http://purl.obolibrary.org/obo/NCIT_C5744) (Gallbladder Mucinous Adenocarcinoma), [NCIT:C5740](http://purl.obolibrary.org/obo/NCIT_C5740) (Stage IV Gallbladder Cancer AJCC v6), [NCIT:C9167](http://purl.obolibrary.org/obo/NCIT_C9167) (Undifferentiated Gallbladder Carcinoma), [NCIT:C9166](http://purl.obolibrary.org/obo/NCIT_C9166) (Gallbladder Adenocarcinoma), [NCIT:C90216](http://purl.obolibrary.org/obo/NCIT_C90216) (Stage I Gallbladder Cancer AJCC v7), [NCIT:C43604](http://purl.obolibrary.org/obo/NCIT_C43604) (Gallbladder Adenocarcinoma, Intestinal-Type), [NCIT:C96919](http://purl.obolibrary.org/obo/NCIT_C96919) (Gallbladder Neuroendocrine Carcinoma), [NCIT:C90512](http://purl.obolibrary.org/obo/NCIT_C90512) (Gallbladder Cancer by AJCC v6 Stage), [NCIT:C43605](http://purl.obolibrary.org/obo/NCIT_C43605) (Gallbladder Clear Cell Adenocarcinoma), [NCIT:C9170](http://purl.obolibrary.org/obo/NCIT_C9170) (Gallbladder Squamous Cell Carcinoma), [NCIT:C90218](http://purl.obolibrary.org/obo/NCIT_C90218) (Stage III Gallbladder Cancer AJCC v7), [NCIT:C91229](http://purl.obolibrary.org/obo/NCIT_C91229) (Gallbladder Cancer by AJCC v7 Stage), [NCIT:C90217](http://purl.obolibrary.org/obo/NCIT_C90217) (Stage II Gallbladder Cancer AJCC v7), [NCIT:C96915](http://purl.obolibrary.org/obo/NCIT_C96915) (Gallbladder Adenocarcinoma, Biliary Type), [NCIT:C90219](http://purl.obolibrary.org/obo/NCIT_C90219) (Stage IV Gallbladder Cancer AJCC v7), [NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma), [NCIT:C134663](http://purl.obolibrary.org/obo/NCIT_C134663) (Stage 0 Gallbladder Cancer AJCC v8), [NCIT:C5737](http://purl.obolibrary.org/obo/NCIT_C5737) (Stage I Gallbladder Cancer AJCC v6), [NCIT:C134667](http://purl.obolibrary.org/obo/NCIT_C134667) (Stage II Gallbladder Cancer AJCC v8), [NCIT:C134665](http://purl.obolibrary.org/obo/NCIT_C134665) (Stage I Gallbladder Cancer AJCC v8), [NCIT:C6763](http://purl.obolibrary.org/obo/NCIT_C6763) (Gallbladder Small Cell Neuroendocrine Carcinoma), [NCIT:C7356](http://purl.obolibrary.org/obo/NCIT_C7356) (Gallbladder Adenosquamous Carcinoma), [NCIT:C134660](http://purl.obolibrary.org/obo/NCIT_C134660) (Gallbladder Cancer by AJCC v8 Stage), [NCIT:C96927](http://purl.obolibrary.org/obo/NCIT_C96927) (Gallbladder Mixed Adenoneuroendocrine Carcinoma), [NCIT:C96928](http://purl.obolibrary.org/obo/NCIT_C96928) (Gallbladder Goblet Cell Carcinoid), [NCIT:C96887](http://purl.obolibrary.org/obo/NCIT_C96887) (Gallbladder Mucinous Cystic Neoplasm with an Associated Invasive Carcinoma), [NCIT:C96888](http://purl.obolibrary.org/obo/NCIT_C96888) (Gallbladder Carcinosarcoma), [NCIT:C96921](http://purl.obolibrary.org/obo/NCIT_C96921) (Gallbladder Large Cell Neuroendocrine Carcinoma), [NCIT:C5738](http://purl.obolibrary.org/obo/NCIT_C5738) (Stage II Gallbladder Cancer AJCC v6), [NCIT:C5838](http://purl.obolibrary.org/obo/NCIT_C5838) (Undifferentiated Gallbladder Carcinoma, Spindle and Giant Cell Type), [NCIT:C5739](http://purl.obolibrary.org/obo/NCIT_C5739) (Stage III Gallbladder Cancer AJCC v6), 

**Class expressions from DL-Learner:**

- Thing 53.00%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39748](http://purl.obolibrary.org/obo/NCIT_C39748) (Lymphoblast-Like Neoplastic B-Lymphocyte))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39747](http://purl.obolibrary.org/obo/NCIT_C39747) (Pleomorphic Variant Mantle Cell Lymphoma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39743](http://purl.obolibrary.org/obo/NCIT_C39743) (Fascicular Pattern))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39741](http://purl.obolibrary.org/obo/NCIT_C39741) (Retroperitoneal Inflammatory Myofibroblastic Tumor))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39740](http://purl.obolibrary.org/obo/NCIT_C39740) (Lung Inflammatory Myofibroblastic Tumor))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39739](http://purl.obolibrary.org/obo/NCIT_C39739) (Negative Peripheral Blood))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39725](http://purl.obolibrary.org/obo/NCIT_C39725) (Immunodeficiency))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39721](http://purl.obolibrary.org/obo/NCIT_C39721) (Abundance of Small Lymphocytes))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39720](http://purl.obolibrary.org/obo/NCIT_C39720) (Classical Reed-Sternberg Cell))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C3972](http://purl.obolibrary.org/obo/NCIT_C3972) (Prostate Fibroma))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39719](http://purl.obolibrary.org/obo/NCIT_C39719) (PDGFRalpha Protein Overexpression))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39718](http://purl.obolibrary.org/obo/NCIT_C39718) (PDGFRA Gene Mutation))) 38.93%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C39717](http://purl.obolibrary.org/obo/NCIT_C39717) (MDM2 Gene Mutation))) 38.93%


